Skywest Inc. (SKYW) Financials Nov 14, 2014, 4:28
Skywest Inc. (SKYW) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Skywest Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.61B 2.77B 3.65B 3.53B 3.3B
Cost of Goods Sold (COGS) incl. D&A 1.31B 1.62B 3.37B 3.14B 2.91B
COGS excluding D&A 1.09B 1.38B 3.11B 2.89B 2.66B
Depreciation & Amortization Expense 221.55M 236.5M 254.18M 251.96M 245.01M
Depreciation 211.85M 224.5M 239.88M - -
Amortization of Intangibles 9.7M 12M 14.3M - -
Gross Income 1.3B 1.15B 287.07M 395.83M 392.35M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 948.93M 764.93M - 0 239.24M
Research & Development 0 0 0 0 0
Other SG&A 948.93M 764.93M - 0 239.24M
Other Operating Expense 141.88M 173.44M 240.19M 229.84M 0
Unusual Expense 7.12M (6.77M) 11.48M 0 0
EBIT after Unusual Expense (7.12M) 6.77M (11.48M) 0 0
Non Operating Income/Expense 1.86M 630,000 (13.42M) (10.64M) 10.39M
Non-Operating Interest Income 11.12M 14.38M 8.24M 7.93M 3.69M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 86.33M 86.52M 80.38M 77.38M 68.66M
Gross Interest Expense 87.17M 86.52M 80.38M 77.38M 69.86M
Interest Capitalized 843,000 5,000 - 0 1.2M
Pretax Income 131.73M 145.9M (50.17M) 85.9M 98.53M
Income Tax 48.08M 49.55M (22.84M) 34.74M 39.58M
Income Tax - Current Domestic (11.2M) (1.15M) 396,000 441,000 2.11M
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 59.27M 50.7M (23.23M) 34.3M 37.47M
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 83.66M 96.35M (27.34M) 51.16M 58.96M
Minority Interest Expense 0 0 0 0 0
Net Income 83.66M 96.35M (27.34M) 51.16M 58.96M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 83.66M 96.35M (27.34M) 51.16M 58.96M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 83.66M 96.35M (27.34M) 51.16M 58.96M
EPS (Basic) 1.50 1.73 (0.52) 1.00 1.14
Basic Shares Outstanding 55.85M 55.61M 52.2M 51.09M 51.69M
EPS (Diluted) 1.47 1.70 (0.52) 0.99 1.12
Diluted Shares Outstanding 56.81M 56.53M 52.2M 51.75M 52.42M
EBITDA 433.74M 447.14M 301.06M 417.95M 398.12M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...
Continue Reading
Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...
Continue Reading
Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...
Continue Reading
The Evolving World of Agrochemicals You know, the agrochemical market isn't just about fertilizers and pesticides anymore. It's evolving into a high-stakes game of innovation, resistance management, and cutting-edge tech. This whole sector's forecast to explode to a whopping US$ 387.7 billion by 2031. That's no small potatoes. Driving Forces: Pests, Drones, and Regulatory...
Continue Reading
Insurify's Game-Changing AI Agent Gateway In the insurance world, Insurify's latest move feels like a bull charging through a ticker tape parade. This Cambridge-based pioneer unveiled its AI Agent Gateway, aiming to put consumers back in the driver's seat. By connecting digital assistant agents to its platform, Insurify's making insurance shopping a bit less like pulling...
Continue Reading
Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...
Continue Reading
Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...
Continue Reading
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...
Continue Reading
A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...
Continue Reading
Top 5 Most Recently Viewed Articles
Gen Z Leads the Charge in AI-Driven Loyalty The times, they are a-changin', and loyalty programs aren't immune. Hopping on the AI bandwagon, 64% of Gen Z in the UK and 55% in the US are getting more bang for their buck, utilizing AI to optimize their participation and rake in rewards. According to Comarch's latest findings, these young savants aren't just after luxury...
Continue Reading
SendCutSend Wins Gold Stevie Award at American Business Awards SendCutSend has received a significant honor by winning a coveted Gold Stevie Award in the Manufacturing category during the American Business Awards. This prestigious award program recognizes excellence in various sectors across the country. The awards attracted over 3,600 submissions from multiple...
Continue Reading
Glow Up Golden 2026 Calendar Unveiled at Pearl River Mart -Inspired by ancient Chinese timing to support modern decision-making- In a vibrant new partnership, Julie Huang, renowned writer and Chinese metaphysics practitioner, is set to launch the Glow Up Golden 2026 Calendar at Pearl River Mart. This culturally enriching calendar draws on classical Chinese wisdom, making...
Continue Reading
Investors Encouraged to Act on Luminar Technologies Lawsuit The focus is now on Luminar Technologies, Inc. (NASDAQ: LAZR) as the opportunity arises for investors to join a significant class action lawsuit. This comes in light of recent allegations of securities fraud within the company. Investors who purchased Luminar securities within the specified time frame are urged...
Continue Reading
Recent Trends in Catalyst Pharmaceuticals' Short Interest Catalyst Pharmaceuticals (CPRX) has seen a notable increase in its short percent of float, jumping by 5.8% since the last report. The latest figures indicate that about 8.17 million shares are currently sold short, representing 8.57% of all shares available for trading. Based on trading volume, it would take...
Continue Reading